\-\ Texto\\:\\ \ \(0\)\
\-\ follow\\ up\\ imaging\\ in\\ 6\\ months\\ was\\ recommended\\.\ \(0\)\
\-\ cystic\\,\\ non\\-enhancing\\ lesion\\ in\\ the\\ tail\\ of\\ the\\ pancreas\\.\ \(1\)\
\-\ serous\\ cystadenoma\\ of\\ the\\ pancreas\ \(0\)\
\-\ serous\\ cystadenoma\\ \\(microcystic\\)\ \(1\)\
\-\ mucinous\\ cystadenoma\\ \\(macrocystic\\)\ \(1\)\
\-\ pseudocyst\ \(40\)\
\-\ intraductal\\ papillary\\ mucinous\\ tumor\\ \\(arising\\ in\\ a\\ side\\ branch\\)\ \(1\)\
\-\ patient\\ noted\\ to\\ have\\ a\\ hypodense\\ lesion\\ in\\ the\\ tail\\ of\\ the\\ pancreas\\ on\\ a\\ non\\-contrast\\ ct\\ obtained\\ for\\ microhematuria\\.\ \(0\)\
\-\ the\\ imaging\\ appearance\\ of\\ a\\ cluster\\ of\\ small\\ cysts\\ in\\ the\\ tail\\ of\\ the\\ pancreas\\,\\ as\\ well\\ as\\ the\\ patient\\'s\\ age\\ and\\ gender\\,\\ favor\\ the\\ diagnosis\\ of\\ a\\ serous\\ cystadenoma\\ \\(microcystic\\ adenoma\\)\\.\\ \\ small\\,\\ cystic\\ pancreatic\\ lesions\\ which\\ are\\ discovered\\ incidentally\\ may\\ often\\ be\\ followed\\ safely\\ \\(ajr\\ 2005\\;\\ 184\\:20\\-23\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cystadenoma\\:\\ 0\\.38904552724978425\ \(0\)\
\-\ pancreas\\:\\ 0\\.3613262241628386\ \(0\)\
\-\ serous\\:\\ 0\\.3314606738289329\ \(0\)\
\-\ tail\\:\\ 0\\.2843738876413687\ \(0\)\
\-\ microcystic\\:\\ 0\\.24433111578005526\ \(0\)\
\-\ mucinous\\:\\ 0\\.20562539190953827\ \(0\)\
\-\ the\\:\\ 0\\.19177711974913692\ \(0\)\
\-\ of\\:\\ 0\\.1316600640772016\ \(0\)\
\-\ safely\\:\\ 0\\.12836126240002302\ \(0\)\
\-\ macrocystic\\:\\ 0\\.12658606894742466\ \(0\)\
\-\ cluster\\:\\ 0\\.12351417781375473\ \(0\)\
\-\ microhematuria\\:\\ 0\\.12091693086754915\ \(0\)\
\-\ in\\:\\ 0\\.11954701740271415\ \(0\)\
\-\ cystic\\:\\ 0\\.1157692839328605\ \(0\)\
\-\ favor\\:\\ 0\\.11490740233370801\ \(0\)\
\-\ gender\\:\\ 0\\.11255258769107124\ \(0\)\
\-\ intraductal\\:\\ 0\\.11183551120003808\ \(0\)\
\-\ pseudocyst\\:\\ 0\\.10923826425383251\ \(0\)\
\-\ ajr\\:\\ 0\\.10752335263443966\ \(0\)\
\-\ imaging\\:\\ 0\\.10101961357980122\ \(0\)\
\-\ small\\:\\ 0\\.09915502047020469\ \(0\)\
\-\ branch\\:\\ 0\\.09428831063600203\ \(0\)\
\-\ hypodense\\:\\ 0\\.09332526255887308\ \(0\)\
\-\ lesion\\:\\ 0\\.0921559109938056\ \(0\)\
\-\ 2005\\:\\ 0\\.091340765117693\ \(0\)\
\-\ papillary\\:\\ 0\\.08956557166509464\ \(0\)\
\-\ discovered\\:\\ 0\\.08762272753167485\ \(0\)\
\-\ pancreatic\\:\\ 0\\.08712955804887769\ \(0\)\
\-\ incidentally\\:\\ 0\\.08188224670127696\ \(0\)\
\-\ as\\:\\ 0\\.0772227413969667\ \(0\)\
\-\ adenoma\\:\\ 0\\.07662491130514586\ \(0\)\
\-\ recommended\\:\\ 0\\.07645210205274527\ \(0\)\
\-\ arising\\:\\ 0\\.07636635757044966\ \(0\)\
\-\ cysts\\:\\ 0\\.072830516476528\ \(0\)\
\-\ obtained\\:\\ 0\\.0679834318902597\ \(0\)\
\-\ side\\:\\ 0\\.06639649463536373\ \(0\)\
\-\ followed\\:\\ 0\\.06490287593026983\ \(0\)\
\-\ often\\:\\ 0\\.06271269916004076\ \(0\)\
\-\ patient\\:\\ 0\\.06252044369636231\ \(0\)\
\-\ age\\:\\ 0\\.060339704487341925\ \(0\)\
\-\ appearance\\:\\ 0\\.057941853411580264\ \(0\)\
\-\ months\\:\\ 0\\.05594462551689858\ \(0\)\
\-\ lesions\\:\\ 0\\.055197881987423376\ \(0\)\
\-\ follow\\:\\ 0\\.051812404411296066\ \(0\)\
\-\ noted\\:\\ 0\\.05095813712786865\ \(0\)\
\-\ tumor\\:\\ 0\\.05027185193060962\ \(0\)\
\-\ diagnosis\\:\\ 0\\.04982348182119815\ \(0\)\
\-\ may\\:\\ 0\\.04836629995997502\ \(0\)\
\-\ have\\:\\ 0\\.04801292895497611\ \(0\)\
\-\ up\\:\\ 0\\.047542700638172036\ \(0\)\
\-\ well\\:\\ 0\\.04653762607047163\ \(0\)\
\-\ which\\:\\ 0\\.04370282148858378\ \(0\)\
\-\ be\\:\\ 0\\.0389885630443517\ \(0\)\
\-\ ct\\:\\ 0\\.03659052210100674\ \(0\)\
\-\ are\\:\\ 0\\.03646991489734019\ \(0\)\
\-\ was\\:\\ 0\\.03349578337280691\ \(0\)\
\-\ for\\:\\ 0\\.02913063547796092\ \(0\)\
\-\ on\\:\\ 0\\.029027300260410463\ \(0\)\
\-\ to\\:\\ 0\\.024027667610759983\ \(0\)\
\-\ and\\:\\ 0\\.019860249414432974\ \(0\)\
